Pitney Bowes, Inc. (PBI): $9.45 and still quiet. Pitney Bowes...

Rigor · 2021-01-26T19:05:26.6900000Z

$9.45 and still quiet. Pitney Bowes - Already Transformed And Set To Shock Market https://seekingalpha.com/article/4401027-pitney-bowes-already-transformed-and-set-to-shock-market

Play Episode

11min

Proactive - Interviews for investors

West Cobar Metals' high-grade copper discovery: Bulla Park delivers exceptional results

West Cobar Metals Ltd (ASX:WC1) managing director Matt Szwedzicki talked with Proactive's Jonathan Jackson about the company’s latest metallurgical results from the Bulla Park project. Early-stage testing has delivered high-grade copper, silver, and antimony concentrates with strong recoveries. Szwedzicki described the initial float test results as amazing. A key challenge at Bulla Park has been the presence of tetrahedrite, a less common mineral in Australia. However, recent testing has demonstrated successful separation and recovery processes. The company has now achieved 88% extraction of antimony, a commodity that has surged in value due to reduced exports from China. Szwedzicki also discussed West Cobar’s broader strategy, including plans to optimise metallurgical processes, assess a mineral resource estimate, and advance drilling at Bulla Park. Beyond this, the company is progressing its Salazar project in Western Australia, which holds rare earths, scandium, and alumina resources. The recent acquisition of the Mystique Gold Project further strengthens West Cobar’s portfolio, adding a promising gold exploration target. Stay tuned for more updates from West Cobar Metals. If you enjoyed this interview, give the video a like, subscribe to Proactive’s YouTube channel, and turn on notifications for the latest mining insights. #WestCobarMetals #Copper #Antimony #Mining #ASX #BullaPark #RareEarths #GoldExploration #Metals #Investing #Resources

Proactive - Interviews for investors

GTI Energy’s Uranium Study Yields Key Results

GTI Energy Ltd CEO Bruce Lane talked with Proactive about the latest developments at the Lo Herma in-situ recovery (ISR) Uranium Project in Wyoming. Lane highlighted key findings from recent scoping study fieldwork, including updated resource estimates of 8.57 million pounds, with 30% in the indicated category. He noted that metallurgical testing produced positive leach test results, aligning with nearby uranium projects. GTI Energy also completed permeability testing and water monitoring wells, confirming sufficient water levels and favourable mineralization conditions for ISR mining. Lane emphasized that these results reinforce the feasibility of uranium extraction at Lo Herma, placing it in line with existing ISR operations in Wyoming. He outlined the company’s next steps, including finalizing the scoping study and preparing for further permitting and potential project expansion. Lane also discussed the strong uranium market fundamentals, citing U.S. utilities' annual demand of 50 million pounds versus current domestic production of only 1–2 million pounds. With growing interest in US-based uranium supply and favourable regulatory conditions, GTI Energy continues to advance its Wyoming uranium assets. For more exclusive interviews and updates, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for the latest insights. #GTIEnergy #UraniumMining #LoHermaProject #ISRMining #WyomingUranium #UraniumStocks #EnergySector #MiningNews #BruceLane #NuclearEnergy

Proactive - Interviews for investors

BioHarvest Sciences achieves breakthrough in Liver health with Olive Cell compound

BioHarvest Sciences has announced a significant advancement in liver health research, with new in vitro test results demonstrating the efficacy of its proprietary Olive Cell compound in reducing fat accumulation in human liver cells. CEO Ilan Sobel shared the news with Steve Darling from Proactive, highlighting the compound’s potential in addressing non-alcoholic fatty liver disease (NAFLD)—a condition that affects 30–40% of U.S. adults and currently has limited FDA-approved treatment options. The latest studies revealed that the Olive Cell compound mitigated fat accumulation in both a liver steatosis model and experimental models of liver fibrosis. Additionally, it reduced collagen type 1 levels in XL-2 cells, a key marker of fibrosis progression, further reinforcing its therapeutic potential. BioHarvest attributes these promising results to the compound’s high levels of Verbascoside, a bioactive polyphenol with anti-inflammatory and antioxidant properties. Looking ahead, the company plans to conduct further studies in 2025, with the goal of launching Olive Cell as a nutraceutical product in 2026. Meanwhile, BioHarvest is also exploring pharmaceutical partnerships to bring the compound to market through a CDMO (Contract Development and Manufacturing Organization) model. With these groundbreaking findings, BioHarvest Sciences is positioning itself at the forefront of liver health innovation, offering a potential new solution for millions affected by NAFLD and liver fibrosis. #proactivinvestors #nasdaq #bhst #pharma #biotech #hearthealth #fattyliverdisease #BioHarvestSciences, #IlanSobel, #RevenueGrowth, #NasdaqListing, #IlanSobel #VINIA #HealthTech #Biotech LiverHealth #OliveCell #Verbascoside #NonAlcoholicFattyLiver #SupplementScience #HealthInnovation

Proactive - Interviews for investors

Wedgemount Resources updates field activities at Huggy Assets, reactivates five wells

Wedgemount Resources CEO Mark Vanry joined Steve Darling from Proactive to provide an update to Proactive on the company's field activities at its recently acquired Huggy Assets. After weather-related delays, Wedgemount has full operations going, including pumping, surface facility optimization, maintenance, chemical treatments, and well workovers. The company's primary focus remains on the Echo and Novice operational areas, where five additional wells have been brought back online. These wells had been inactive for a significant period before Wedgemount's acquisition. Historical initial production (IP) rates for these wells ranged from 15 to 65 barrels of oil equivalent per day (boepd). Vanry noted that previous successful chemical stimulations on Wedgemount’s Willowbend leases resulted in improved well performance. The company expects similar or better results from workovers and chemical treatments at Huggy, potentially exceeding the original IP rates. Looking ahead, Wedgemount has over 100 additional wells that have yet to undergo chemical stimulation, presenting significant production upside over the next two years. #proactiveinvestors #westmountreosurcescorp #cse #wdgy #otcqb #wdgrf #OilProduction #TexasEnergy #EnergyInvesting #OilandGas #MarkVanry #ProactiveInvestors #EnergyStocks #Investing #OilExploration

Followers	3
Posts	190
Boards Moderated	0
Alias Born	11/27/2010

Volume:	1,934,220
Day Range:	9.075 - 9.48
Bid:
Ask:
Last Trade Time:	7:00:00 PM EDT
Total Trades:	18,951

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

PBI Detailed Quote

Recent PBI News

More PBI News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent PBI News

Go Ad-Free